136 related articles for article (PubMed ID: 2536252)
1. Laudanosine does not displace receptor-specific ligands from the benzodiazepinergic or muscarinic receptors.
Katz Y; Gavish M
Anesthesiology; 1989 Jan; 70(1):109-11. PubMed ID: 2536252
[TBL] [Abstract][Full Text] [Related]
2. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
3. Soman- or kainic acid-induced convulsions decrease muscarinic receptors but not benzodiazepine receptors.
Churchill L; Pazdernik TL; Cross RS; Nelson SR; Samson FE
Neurotoxicology; 1990; 11(1):57-71. PubMed ID: 2165227
[TBL] [Abstract][Full Text] [Related]
4. Effects of the methylxanthine derivative pentoxifylline on benzodiazepine and muscarinic binding sites in rat cerebral cortex.
Lowenstein PR; Aguilar JS; Sabato UC
Acta Physiol Pharmacol Latinoam; 1985; 35(4):431-9. PubMed ID: 3012947
[TBL] [Abstract][Full Text] [Related]
5. Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites.
Awad M; Gavish M
J Neurochem; 1987 Nov; 49(5):1407-14. PubMed ID: 2822854
[TBL] [Abstract][Full Text] [Related]
6. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
7. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
8. The peripheral-type benzodiazepine receptor ligands [3H]Ro 5-4864 and [3H]PK 11195 bind to the retina of rabbit, but not of turtle.
Giannaccini G; Martini C; Lucacchini A; Strettoi E; Piccolino M
J Neurochem; 1993 Oct; 61(4):1263-9. PubMed ID: 8397291
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic chlorpromazine treatment on peripheral benzodiazepine binding sites in heart, kidney, and cerebral cortex of rats.
Gavish M; Weizman R
J Neurochem; 1989 May; 52(5):1553-8. PubMed ID: 2540276
[TBL] [Abstract][Full Text] [Related]
10. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
Gao ZG; Liu CG
Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
[TBL] [Abstract][Full Text] [Related]
11. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
12. Plasticity-related binding of GABA and muscarinic receptor sites in piriform cortex of rat: an autoradiographic study.
Thomas AP; Westrum LE
Exp Neurol; 1989 Sep; 105(3):265-71. PubMed ID: 2548889
[TBL] [Abstract][Full Text] [Related]
13. Interactions between laudanosine, GABA, and opioid subtype receptors: implication for laudanosine seizure activity.
Katz Y; Weizman A; Pick CG; Pasternak GW; Liu L; Fonia O; Gavish M
Brain Res; 1994 May; 646(2):235-41. PubMed ID: 8069669
[TBL] [Abstract][Full Text] [Related]
14. Disulfiram and diethyldithiocarbamate are competitive inhibitors at the peripheral benzodiazepine receptor.
Katz Y; Weizman R; Weizman A; Gavish M
J Pharmacol Exp Ther; 1992 Jul; 262(1):394-7. PubMed ID: 1320691
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
Lee JH; el-Fakahany EE
J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
[TBL] [Abstract][Full Text] [Related]
16. Quantitative autoradiography of muscarinic and benzodiazepine receptors in the forebrain of the turtle, Pseudemys scripta.
Schlegel JR; Kriegstein AR
J Comp Neurol; 1987 Nov; 265(4):521-9. PubMed ID: 2828438
[TBL] [Abstract][Full Text] [Related]
17. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
18. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
19. Long-term alterations in benzodiazepine, muscarinic and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor density following continuous cocaine administration.
Keys AS; Ellison GD
Pharmacol Toxicol; 1999 Sep; 85(3):144-50. PubMed ID: 10522755
[TBL] [Abstract][Full Text] [Related]
20. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
